PETRAV:Travoprost 0.004% 40mcg/ml

PETRAV

COMPOSITION:

Travoprost 0.004% 40mcg/ml

PACKING:

3ml

🩺 Product Description

PETRAV Eye Drops contain Travoprost 0.004%, a prostaglandin analog specifically designed for the treatment of elevated intraocular pressure (IOP) in patients with open-angle glaucoma and ocular hypertension. Travoprost is a once-daily medication clinically proven to lower IOP by increasing the outflow of aqueous humor through the trabecular meshwork and uveoscleral pathways.Its powerful IOP-lowering action, combined with excellent tolerability and patient compliance, makes PETRAV an ideal choice for long-term glaucoma management.

Indications – PETRAV Eye Drops (Travoprost 0.004%)

PETRAV Eye Drops are specially indicated for the treatment of elevated intraocular pressure (IOP), a key risk factor in optic nerve damage and vision loss. Its active ingredient, Travoprost 0.004%, is a potent prostaglandin analog clinically proven to enhance aqueous humor outflow, thereby reducing eye pressure effectively and safely.PETRAV is widely recommended for the following ophthalmic conditions:

🔹 Primary Open-Angle Glaucoma (POAG):
PETRAV is highly effective in reducing intraocular pressure in patients diagnosed with primary open-angle glaucoma, the most common form of glaucoma. This condition progresses silently and may result in irreversible blindness if left untreated. PETRAV helps prevent optic nerve damage by maintaining optimal IOP levels.

🔹 Ocular Hypertension (OHT):
In patients with increased eye pressure but no visible damage to the optic nerve, PETRAV acts as a preventive treatment. It reduces IOP to safe levels, minimizing the risk of glaucoma development.

🔹 Patients Unresponsive or Intolerant to Beta-Blockers or Other IOP-Lowering Agents:
PETRAV is an excellent alternative for individuals who either do not respond adequately to first-line therapies such as Timolol or Brimonidine, or experience side effects. Its once-daily dosing and non-beta-blocker mechanism make it ideal for long-term use.  Our Products

✅ Key Features & Benefits

• 🌟 Effective IOP Reduction: Starts lowering IOP within hours; peak effect within 8–12 hours.
• 🌙 Once-Daily Dosing: Improves patient adherence and convenience.
• 👁️‍🗨️ Preserved Vision: Slows progression of optic nerve damage and visual field loss.
• 🧪 Well-Tolerated Formula: Minimal systemic absorption and low incidence of side effects.
• 🧴 Sterile Multi-dose Bottle: Easy to use with accurate dropper tip.

🧑‍⚕️ Doctor’s Tip

“For my glaucoma patients who need consistent and effective IOP control, I often recommend PETRAV Eye Drops. Its once-daily Travoprost formulation ensures strong pressure reduction with excellent long-term safety.

Home